The signature of the development contract, along with a consultancy contract signed in parallel, will provide Viropro with product development and licensing revenues of $2.14 million over the
Centers for Disease Control (CDC) refers to chronic fatigue syndrome (CFS) as a ‘disabling disease, as disabling as other severe chronic conditions like multiple sclerosis, COPD (chronic obstructive
Currently, Samaritan has the marketing rights for Amphocil (amphotericin B cholesteryl sulfate) in Greece and Cyprus, and has successfully registered and obtained a price increase for Amphocil in
The program, involving approximately 2,200 chronic renal failure patients, consists of four trials in the US and Europe, including two trials in patients on dialysis and two trials
Deforolimus is designed to prevent restenosis of injured vessels following interventions in which stents are used in conjunction with balloon angioplasty. As part of the agreement, Ariad will
Zingo provides fast-acting topical, local analgesia, to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children three to 18 years
The collaboration aims to combine the malaria drug data and informatics technology of Collaborative Drug Discovery with the drug discovery expertise of the St. Jude department of chemical
Thelin is the first selective endothelin A receptor antagonist, in the form of 100mg once-daily oral tablets. Thelin is indicated for improving exercise capacity in pulmonary arterial hypertension
The proportion of disease-free patients in the Affirm (Antegren safety and efficacy in relapsing-remitting multiple sclerosis) study was determined based upon clinical and MRI criteria. The proportion of
In connection with the clearance, Schering-Plough has agreed to divest certain animal health products in Europe. The divestitures are not material to the company’s financial results. No divestitures
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.